Company · CIK 1177648
ENANTA PHARMACEUTICALS INC
| CIK | 1177648 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Business address | MA |
| Listed | ENTA (Nasdaq) |
| First annual or quarterly report | 2013-05-15 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-293390 | 2026-02-11 | 2026-07-02 | 3 | |
| 333-275723 | 2023-11-22 | 2025-10-01 | 4 | |
| 333-258632 | 2021-08-09 | 2022-08-26 | 2 | |
| 333-184779 | 2012-11-06 | 2013-03-21 | 8 |
Filings
17| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-07-02 | 424B5Shelf takedown | 333-293390 | 0001193125-26-294828 |
| 2026-02-20 | EFFECTDeclared effective | 333-293390 | 9999999995-26-000642 |
| 2026-02-11 | S-3Shelf registered | 333-293390 | 0001193125-26-046712 |
| 2025-10-01 | 424B5Shelf takedown | 333-275723 | 0001193125-25-226794 |
| 2025-09-30 | 424B5Shelf takedown | 333-275723 | 0001193125-25-225149 |
| 2024-02-08 | EFFECTDeclared effective | 333-275723 | 9999999995-24-000353 |
| 2023-11-22 | S-3Shelf registered | 333-275723 | 0001193125-23-282292 |
| 2022-08-26 | 424B5Shelf takedown | 333-258632 | 0001193125-22-231299 |
| 2021-08-09 | S-3ASRShelf registered | 333-258632 | 0001564590-21-042633 |
| 2013-03-21 | 424B4Final prospectus | 333-184779 | 0001193125-13-119725 |
| 2013-03-20 | EFFECTDeclared effective | 333-184779 | 9999999995-13-000755 |
| 2013-03-14 | S-1/AAmendment | 333-184779 | 0001193125-13-107174 |
| 2013-03-05 | S-1/AAmendment | 333-184779 | 0001193125-13-091763 |
| 2013-02-05 | S-1/AAmendment | 333-184779 | 0001193125-13-038960 |
| 2012-12-18 | S-1/AAmendment | 333-184779 | 0001193125-12-506306 |
| 2012-11-16 | S-1/AAmendment | 333-184779 | 0001193125-12-474268 |
| 2012-11-06 | S-1Registration filed | 333-184779 | 0001193125-12-454422 |